Home About Us Contact Us

Official Journals By StatPerson Publication

Table of Content Volume 9 Issue 2 - February 2019

 

.

A prospective randomised comparative study of efficacy of combination of inj. exmedetomidine–propofol and inj.fentanyl-propofol for the insertion conditions of proseal laryngeal mask airway

 

Prashanth Vadigeri1, Ramesh Babu2*, Mohan3, Sunil Kumar4, Rajashekar Mudaraddi5

 

1Senior Resident, 2Associate Professor, 3,5Assistant Professor, Department of Anaesthesiology, Navodaya Medical College and Hospital, Raichur, INDIA.

4Associate Professor, Department of Anaesthesiology, Raichur Institute of Medical Sciences, Raichur, INDIA.

Email: rsjev6313@gmail.com

 

Abstract               Background: Dexmedetomidine over a period of time has been studied with Propofol as a co-induction agent to assess the haemodynamic response, Propofol dose requirement and overall insertion condition of laryngeal mask airway. Objective: To compare efficacy of anesthetic drug with respect to hemodynamic effects during insertion of PLMA. Methodology: It is randomised prospective study was conducted on 94 ASA I and II patients satisfying inclusion criteria, aged 18–60 years of either sex. They were divided into two groups using randomisation in a group of 47 patients named as group D, which received Dexmedetomidine with Propofol and group F, which received Fentanyl with Propofol. Results: Majority i.e. 35(74.5%) and 39(83%) from group D and F respectively were from ASA I. dose of Propofol required per kg body weight, in group D-P 1.6 mg/kg and in group F-P its 1.9 mg/kg to insert PLMA. . Average time required for insertion of PLMA in-group D-P is 33.10 sec while in-group F-P is 35.6sec. Though group F-P shows rise in heart rate at the time of insertion of PLMA, the values are statistically comparable in both the groups. mean systolic blood pressure is significantly higher in group F-P. Conclusion: Dexmedetomidine has better potential as a co -induction agent used with Propofol for insertion of PLMA in short surgical procedures in given doses with improved overall insertion conditions and better haemodynamic profile than Fentanyl.

Key Word: Dexmedetomidine–Propofol, Fentanyl-Propofol, Proseal Laryngeal Mask Airway

 

 

INTRODUCTION

Endotracheal intubation, first used in anaesthesia in 1878, is a rapid, simple, safe and non-surgical technique that achieves all the goals of airway management, hence remains the gold standard for airway management with its problems. It often requires neuromuscular blockade, stimulates the unwanted reflex activity and may damage the vocal cords and tracheal mucosa1. Though supraglottic airways provide an adequate airway, the risk of aspiration always remains. Hence Proseal Laryngeal Mask Airway (PLMA) was introduced. PLMA has a softer silicone cuff reducing the throat irritation. It has a high seal pressure hence provides a tighter seal against the glottic opening. PLMA has a dorsal cuff, in addition to the peripheral cuff of LMA, which pushes the mask anterior to provide a better seal around the glottic aperture2 with a tighter seal without increasing pressure on the mucosa and permits high airway pressures without leak. For the use of PLMA different induction agents used over a period of time for rapid and smooth insertion of PLMA with minimum alteration of haemodynamic responses and insertion conditions are Propofol3, Thiopentone4, Sevoflurane3 etc. Propofol is non-opioid, non-barbiturate, sedative-hypnotic agent with rapid induction and recovery time and anti-emetic effect5. Propofol 2.5–3.0 mg/kg is considered as the induction agent of choice for PLMA insertion6. It is used to facilitate insertion of laryngeal mask airway, because it has a short duration of action and a rapid recovery. In addition, it is known to cause dose dependent cardio-respiratory depression, injection site pain. It has no analgesic property5. It depresses pharyngeal and laryngeal reflexes7. Propofol decreases blood pressure and heart rate, as it directly suppresses peripheral vascular resistance, decreases myocardial contractility and reduces sympathetic tone5 Dexmedetomidine is a pharmacologically active dextro isomer of medetomidine, which displays specific and selective α-2 adrenoceptor agonism. It is found to reduce dose requirement of Propofol to produce unconsciousness and loss of eyelash reflexes8,9. Dexmedetomidine over a period of time has been studied with Propofol as a co-induction agent to assess the haemodynamic response, Propofol dose requirement and overall insertion condition of laryngeal mask airway9,10,11. In this study, we aim to evaluate the effects of Dexmedetomidine versus Fentanyl with Propofol as an induction agent on the insertion conditions, haemodynamic conditions during insertion of PLMA and total and incremental dose requirement of Propofol.

 

METHODOLOGY

After institutional ethics committee approval, this study was conducted on 94 ASA I and II patients satisfying inclusion criteria, aged 18–60 years of either sex scheduled for short surgical procedures under general anaesthesia. It was randomised prospective study. They were divided into two groups using randomisation in a group of 47 patients each by a blinder by chit block method (block of 6). And they were named as group D, which received Dexmedetomidine with Propofol and group F, which received Fentanyl with Propofol. A complete pre-operative assessment was done and checked out for patient’s fitness. Patients were assessed for all inclusion and exclusion criteria.

Inclusion criteria

  • ASA Class I and II
  • Age 18-50 years.
  • Obesity BMI<30wt/m2
  • Mouth opening > 2.5cm
  • Mallampatti grade 1 and 2
  • GA with short surgical procedure

Exclusion criteria

  • Anticipated difficult airway
  • Patient undergoing oral and neck surgeries
  • Heart rate < 50bpm
  • Blood pressure < 90/60mm of Hg
  • Allergic to propofol or dexmeditomedine or fentanyl
  • Pregnant female
  • Known case of asthama , reactive airway , URTI
  • Edentulous and patients with dentures

Parameters like heart rate, blood pressure (systolic, diastolic and mean), saturation and respiratory rate was noted after giving premedication.

Statistical analysis: Mean and standard deviation for all the values were calculated and compared between two groups, group D-P and group F-P. For analysis of demographic data either Mann Whitney test or Fisher’s exact test were used. Ordinal categorical data such as PLMA insertion conditions and number of attempts were analyzed with either Fisher’s exact test or Chi Square test and the haemodynamic parameters were analyzed by using either unpaired T test or Mann Whitney test. A p value < 0.05 was accepted as statistically significant


 

RESULTS

Table 1: Distribution of cases according to ASA between study groups

ASA

DP

FP

p value

N

 

N

 

I

35

74.5

39

83.0

0.313

II

12

25.5

8

17.0

Total

47

100.0

47

100.0

Majority i.e. 35(74.5%) and 39(83%) from group D and F respectively were from ASA I. p > 0.05 is statistically not significant and the groups are comparable. ASA physical status of the patients selected in this study were comparable (p=0.313) and there is no statistically significant difference in both the groups.

 

Table 2: Comparison of mean dose of propofol per kg body weight(mg/kg)

Parameter

DP

FP

p value

Mean

SD

Mean

SD

DOSE

(mg/kg

 

1.6

 

0.3

 

1.9

 

0.3

 

<0.001*

Note: *means significant at 5% level of significance (p<0.05)

It shows the dose of Propofol required per kg body weight, in group D-P 1.6 mg/kg and in group F-P its 1.9 mg/kg to insert PLMA. According to Mann Whitney test p value <0.0001. The induction dose in the F-P group is significantly higher than in the D-P group.

Figure 1: Comparison of mean time between study groups

Figure 1 shows comparison time required for insertion of PLMA between two groups D-P and F-P. Average time required for insertion of PLMA in-group D-P is 33.10 sec while in-group F-P is 35.6sec.


Table 3: Change in mean Heart rate according to time between study groups

HR

DP

FP

p value

Mean

SD

Mean

SD

Premedication

91.3

12.4

91.1

9.5

0.941

Before induction

93.5

12.4

94.8

9.3

0.575

After induction

97.8

17.4

99.1

10.1

0.665

After LMA insertion

99.7

14.9

104.5

10.5

0.076

1 min after insertion

94.4

13.5

97.6

8.4

0.172

3 min after insertion

88.7

12.7

90.6

7.4

0.384

5 min after insertion

87.2

13.7

86.4

7.6

0.732

10 min after insertion

85.2

14

86

5.9

0.702

15 min after insertion

83.9

11.9

84

6.1

0.965

20 min after insertion

82.4

11.6

81.5

5.6

0.65

Table shows comparison of mean heart rate between group D-P and group F-P. Though group F-P shows rise in heart rate at the time of insertion of PLMA, the values are statistically comparable in both the groups.

Table 4: Change in mean SBP according to time between study groups

SBP

DP

FP

p value

Mean

SD

Mean

SD

Premedication

117.7

15.1

116

10.7

0.519

Before induction

117.1

13.8

116.5

9.9

0.817

After induction

108.7

11

112.5

10.9

0.097

After LMA insertion

110.9

11.5

117.7

10.8

0.004*

1 min after insertion

108.3

11.1

114.7

10.2

0.005*

3 min after insertion

107.1

9.1

109.7

8.3

0.159

5 min after insertion

105.6

8.3

108.9

8.5

0.059

10 min after insertion

105.4

7.6

107.9

7.8

0.126

15 min after insertion

108.2

7.2

109.9

6.7

0.227

20 min after insertion

107.4

6.8

109.3

7.1

0.195

Note: *means significant at 5% level of significance (p<0.05)

Table shows comparison of systolic blood pressure between two groups. Mean systolic blood pressure after PLMA insertion in group D-P is 110.9 and group F-P is 117.7, which is calculated by unpaired T test with p value 0.024 and this is statistically significant. Thus mean systolic blood pressure is significantly higher in group F-P. Similarly mean systolic blood pressure 1 minute after PLMA insertion in group D-P is 108.3 and in group F-P is 114.7, which is higher in group F-P.

Table 5: Change in mean DBP according to time between study groups

DBP

DP

FP

p value

Mean

SD

Mean

SD

Premedication

77.1

11

75.7

10.2

0.512

Before induction

76.3

11.3

76.9

10.6

0.778

After induction

72.4

10

76

10.9

0.095

After LMA insertion

75.8

11

77.9

10.2

0.344

1 min after insertion

74

10.9

76.8

8.8

0.18

3 min after insertion

73.4

8.9

76.3

8.5

0.109

5 min after insertion

72.1

8

74.9

8

0.098

10 min after insertion

71.4

8

73.7

7.8

0.163

15 min after insertion

71.6

7.7

73.7

6.8

0.161

20 min after insertion

71

7.8

73

6

0.166

Table 18 and figure 18 shows comparison of mean diastolic blood pressure between groups D-P and group F-P. All the mean values calculated and compared statistically and found to be statistically not significant and mean diastolic blood pressure In both groups is comparable.

 

Table 6: Comparison of mean spo2% between study groups

 

DP

FP

p value

Mean

SD

Mean

SD

SPO2%

98.9

0.6

98.8

0.7

0.430

There is no difference in Oxygen saturation of two groups (p>0.05)

DISCUSSION

Insertion conditions were assessed only after the first attempt of PLMA insertion by the Young’s criteria, Limb and head movements, coughing and gagging, laryngospasm and lacrimation. These overall conditions were summed up by modified scheme of Lund and Stovener. These parameters were based on study conducted by Asha Gupta12 and colleagues. In this study 41 patients of F-P group and 34 patients in D-P group had absolutely relaxed jaw. The overall insertion conditions were excellent by modified scheme of Lund and Stovener in which 41/47 patients from D-P group and 34/47 patients from F-P group had excellent insertion conditions. Apnoea >30 sec is known to occur after Inj. Fentanyl followed by Propofol induction. In this study 10/47 patients in F-P group and 2/47 patients in D-P group had apnoea.

Similarly, Sowmya Jayaram et al13 also found higher incidence of apnoea in F-P group, 22/30 (73.33%) than in group D-P, 12/30 (40%) patients. In this study the average time required for PLMA insertion for group D-P is 33.1sec while for group F-P is 35.5sec. group F-P required more time compared to group D-P, still the data is statistically not significant. Bimla Sharma et al14 showed that the PLMA is a safe airway device in patients undergoing laparoscopic surgery as judged by stable haemodynamics, good oxygenation and adequate ventilation. Suparto et al10 compared Dexmedetomidine and Fentanyl for attenuating sympathetic responses to laryngoscopy and intubation and they found that decrease in heart rate in Dexmedetomidine group is significantly lower than in Fentanyl group (p 0.000). Here in this study baseline heart rate was nearly similar in both groups initially. Heart rate in group D-P and group F-P was gradually decreased after induction but there was transient rise in heart rate at the time of insertion of PLMA then till the time we recorded the values it was less than baseline heart rate. The rise in heart rate is higher in group F-P than in group D-P, and this finding is similar to study conducted by Surabhi Lande et al11. Systolic blood pressure found to rise in group F-P at the time of insertion of PLMA and 1 min after insertion of PLMA and this difference found to be statistically significant with p value < 0.05. After 1 min of PLMA insertion systolic blood pressure found to be in decreasing trend in both groups though the mean SBP in group F-P was higher than group D-P. These findings are resembling with study conducted by Surabhi Lande et al11.Diastolic blood pressure in our study had decreasing trend after induction of patient in both groups. Mean DBP in group F-P was higher in group D-P till the end of study though this difference is not statistically significant. There was a rise in diastolic blood pressure after insertion of PLMA in both groups which was falling after 1 min of insertion till the end of study. Regarding adverse events 4 patients in group F-P had evidence of blood stains around the cuff that was seen after removal of PLMA following the surgical procedure, probably from the oropharyngeal mucosa. There was no evidence of gastric regurgitation in both groups. No trauma to lips, tongue and teeth was found. It can be said that when PLMA is being used for short surgical procedures, Propofol is a preferred induction agent. The dose of Propofol when used alone is neither satisfactory for smooth insertion of PLMA nor from haemodynamic point of view. Thus the Dexmedetomidine, used in a dose of 1 mcg/kg gives better insertion conditions and haemodynamic stability compared to Fentanyl used in a dose of 1 mcg/kg.

 

CONCLUSION

Use of Dexmedetomidine also reduces the requirement of induction and incremental doses of Inj. Propofol. Attenuation of haemodynamic responses is also better with use of Dexmedetomidine as an adjuvant, compared to use of Fentanyl as an adjuvant. Thus Dexmedetomidine has better potential as a co -induction agent used with Propofol for insertion of PLMA in short surgical procedures in given doses with improved overall insertion conditions and better haemodynamic profile than Fentanyl.

 

REFERENCES

  1. Brandt L.The first reported oral intubation of human trachea. Anesth Analg 1987;66:1198-9.
  2. Namita Saraswat, Aditya Kumar, Abhijeet Mishra, Amrita Gupta, Gyan Saurabh, and Uma Srivastava. The comparison of proseal laryngeal mask airway and endotracheal tube in patients undergoing laproscopic surgeries under general anaesthesia. Indian J Anaesth. 2011 Mar-Apr; 55(2): 129–134.
  3. Mamta G. Patel, V. N. Swadia, Saya Raghavendra. Comparison of Propofol and Sevoflurane for Insertion of PLMA. JAnaesth Clin harmacol 2010; 26(1): 74-78.
  4. Khanduja S, Ohri A, Panwar M. Dexmedetomidine decreases requirement of thiopentone sodium and pentazocine followed with improved recovery in patients undergoing laparoscopic cholecystectomy. Journal of Anaesthesiology Clinical Pharmacology. 2014;30(2):208.
  5. Gamal T. yousef, Khalid M. Elsayed. Aclinical comparison of ketofol ( a ketamine and Propofol admixture) versus Propofol as an induction agent on quality of insertion of laryngeal mask airway insertion and hemodynamic stability in children. Anesthesia: essay and researches2013; 7(2);194-199.
  6. Furuya A, Matsukawa T, Ozaki M, Nishiyama T, Kume M, Kumazawa T. intravenous ketamine attenuates arterial pressure changes during the induction of anaesthesia with Propofol. Europian Journal of Anaesthesiology 2001; 18: 88-92.
  7. Handa-Tsutsui F, Kodaka M. Propofol concentration requirement for laryngeal mask airway insertion was heighest with ProSeal, next heighest with Fastrach, and lowest with classic type, with target controlled infusion. Journal of clinical anesthesia 2005;17:344-7.
  8. Le Guen M, Liu N, Tounou F, Auge M, Tuil O, Chazot T, Dardelle D, Laloe PA, Bonnet F, Sessler DI, Fishchler M; Anesth Analg. 2014; 118(5): 946-55.
  9. F Uzumcugil, O canbay, N Celebi,A H Karagoz,S Ozgen. Comparison of Dexmedetomidine-Propofol vs. Fentanyl-Propofol for Laryngeal Mask insertion. European journal of anaesthesiology 2008;25(8):675-80.
  10. Suparto, Olivia C. Flores, Clarissa Angela A. Layusa. A randomized controlled trial on the Effectiveness of Dexmedetomedine versus Fentanyl. Maj Kdot Indon, 2010(60); 3.
  11. Lande SA, C P G, A R B, Aich S. comparison of dexmedetomidine propofol v i rus fentanyl – propofol for conditions of laryngeal mask airway insertion in elective surgeries. Journal of Evolution of Medical and Dental Sciences. 2014 Apr 14;3(15):4042–51.
  12. Asha Gupta, Sarabjit Kaur. Comparative evaluation of ketamine- Propofol,Fentanyl-propofol and butarphanol-propofol on haemodynamics and LMA insertion conditions.J Anaesth Clin Pharmacol 2011;27(1) : 74- 78.
  13. Sowmya               Jayaram               A, PJanakiSubhadra, M. hanumantha Rao. Comparison of Dexmedetomidine combinedwith Propofol versus Fentanyl combined with Propofol for laryngeal mask insertion. J Clin Sci Res 2014;3:228-36.
  14. Bimla Sharma, Chand Sahai, Abhijit Bhattacharya, V. P. Kumra, Jyashree Sood Proseal laryngeal mask airway: a consecutive study of 100 cases of laparoscopic study. Indian J. aneasth; 47 (6): 467-472.